Icing treatment in rats with crush syndrome can improve survival through reduction of potassium concentration and mitochondrial function disorder effect

Murata,Isamu; Imanari,Mayuki; Komiya,Marise; Kobayashi,Jun; Inoue,Yutaka; Kanamoto,Ikuo

doi:10.3892/etm.2019.8230

Icing treatment in rats with crush syndrome can improve survival through reduction of potassium concentration and mitochondrial function disorder effect

Authors:
- Isamu Murata
- Mayuki Imanari
- Marise Komiya
- Jun Kobayashi
- Yutaka Inoue
- Ikuo Kanamoto
View Affiliations

Affiliations: Laboratory of Drug Safety Management, Faculty of Pharmacy and Pharmaceutical Science, Josai University, Sakado, Saitama 350‑0295, Japan, Division of Pathophysiology, Department of Clinical Dietetics and Human Nutrition, Faculty of Pharmacy and Pharmaceutical Science, Josai University, Sakado, Saitama 350‑0295, Japan
Published online on: November 22, 2019 https://doi.org/10.3892/etm.2019.8230
Pages: 777-785

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Crush syndrome (CS), a serious medical condition, which is characterized by damage to myocytes due to pressure and is associated with high mortality, even when patients receive fluid therapy. Icing therapy over the affected muscle has been reported to be effective in improving mitochondrial dysfunction and inflammation. These effects are thought to be secondary to improvements in the leakage of potassium and myoglobin from the damaged myocytes in the early stages of disease. However, their effects on the various symptoms of CS are unclear. It was hypothesized that treatment with icing will inhibit the influence of potassium by vasoconstriction, exert anti‑inflammatory effects in the affected myocytes and improve mitochondrial function The CS model constructed by subjecting anesthetized rats to bilateral hindlimb compression with a rubber tourniquet for 5 h. The rats were then randomly divided into six groups: i) Sham; ii) CS without treatment (CS); iii) and iv) icing for 30 or 180 min over the entire hindlimb on CS rats (CI‑30 and ‑180), respectively; and v) and vi) local icing for 30 or 180 min over the affected area on CS rats (CLI‑30 and ‑180), respectively. Under continuous monitoring and recording of arterial blood pressures, blood and tissue samples were collected for biochemical analyses at designated time points prior to and following reperfusion. The survival rate, vital signs, and blood gas parameters in the CS group were lethal compared with the sham group. These were also improved in the CI‑30 and CLI‑30 groups compared with the CS group; however, they worsened in the CI‑180 and CLI‑180 groups due to hypothermia. The CI‑30 and CLI‑30 groups demonstrated tendencies of improvements compared with the CS group. Systemic inflammation and mitochondria dysfunction had improved in these groups compared with the CS group. We suggest icing therapy to temporarily prolong the viability after crush injury. Its effectiveness can be improved by combining it with other infusion therapies.

View Figures

View References

1	Smith J and Greaves I: Crush injury and crush syndrome: A review. J Trauma. 54((5 Suppl)): S226–S230. 2003.PubMed/NCBI
2	Sever MS and Vanholder R; RDRTF of ISN Work Group on Recommendations for the Management of Crush Victims in Mass Disasters, : Recommendation for the management of crush victims in mass disasters. Nephrol Dial Transplant. 27 (Suppl 1):i1–i67. 2012. View Article : Google Scholar : PubMed/NCBI
3	Gonzalez D: Crush syndrome. Crit Care Med. 33((1 Suppl)): S34–S41. 2005. View Article : Google Scholar : PubMed/NCBI
4	Ashkenazi I, Isakovich B, Kluger Y, Alfici R, Kessel B and Better OS: Prehospital management of earthquake casualties buried under rubble. Prehosp Disaster Med. 20:122–133. 2005. View Article : Google Scholar : PubMed/NCBI
5	Murata I, Ooi K, Sasaki H, Kimura S, Ohtake K, Ueda H, Uchida H, Yasui N, Tsutsui Y, Yoshizawa N, et al: Characterization of systemic and histologic injury after crush syndrome and intervals of reperfusion in a small animal model. J Trauma. 70:1453–1463. 2011. View Article : Google Scholar : PubMed/NCBI
6	Murata I, Abe Y, Yaginuma Y, Yodo K, Kamakari Y, Miyazaki Y, Baba D, Shinoda Y, Iwasaki T, Takahashi K, et al: Astragaloside-IV prevents acute kidney injury and inflammation by normalizing muscular mitochondrial function associated with a nitric oxide protective mechanism in crush syndrome rats. Ann Intensive Care. 7:902017. View Article : Google Scholar : PubMed/NCBI
7	Tiidus PM: Alternative treatments for muscle injury: Massage, cryotherapy, and hyperbaric oxygen. Curr Rev Musculoskelet Med. 8:162–167. 2015. View Article : Google Scholar : PubMed/NCBI
8	Merrick MA, Rankin JM, Andres FA and Hinman CL: A preliminary examination of cryotherapy and secondary injury in skeletal muscle. Med Sci Sports Exerc. 31:1516–1521. 1999. View Article : Google Scholar : PubMed/NCBI
9	Jahandiez V, Cour M, Bochaton T, Abrial M, Loufouat J, Gharib A, Varennes A, Ovize M and Argaud L: Fast therapeutic hypothermia prevents post-cardiac arrest syndrome through cyclophilin D-mediated mitochondrial permeability transition inhibition. Basic Res Cardiol. 112:352017. View Article : Google Scholar : PubMed/NCBI
10	Singh DP, Barani Lonbani Z, Woodruff MA, Parker TJ, Steck R and Peake JM: Effects of topical icing on inflammation, angiogenesis, revascularization, and myofiber regeneration in skeletal muscle following contusion injury. Front Physiol. 8:932017. View Article : Google Scholar : PubMed/NCBI
11	Takagi R, Fujita N, Arakawa T, Kawada S, Ishii N and Miki A: Influence of icing on muscle regeneration after crush injury to skeletal muscles in rats. J Appl Physiol (1985). 110:382–388. 2011. View Article : Google Scholar : PubMed/NCBI
12	Meeusen R and Lievens P: The use of cryotherapy in sports injuries. Sports Med. 3:398–414. 1986. View Article : Google Scholar : PubMed/NCBI
13	Swenson C, Swärd L and Karlsson J: Cryotherapy in sports medicine. Scand J Med Sci Sports. 6:193–200. 1996. View Article : Google Scholar : PubMed/NCBI
14	Alegre LM, Hasler M, Wenger S, Nachbauer W and Csapo R: Does knee joint cooling change in vivo patellar tendon mechanical properties? Eur J Appl Physiol. 116:1921–1929. 2016. View Article : Google Scholar : PubMed/NCBI
15	Warren TA, McCarty EC, Richardson AL, Michener T and Spindler KP: Intra-articular knee temperature changes: Ice versus cryotherapy device. Am J Sports Med. 32:441–445. 2004. View Article : Google Scholar : PubMed/NCBI
16	Dewhurst S, Macaluso A, Gizzi L, Felici F, Farina D and De Vito G: Effects of altered muscle temperature on neuromuscular properties in young and older women. Eur J Appl Physiol. 108:451–458. 2010. View Article : Google Scholar : PubMed/NCBI
17	Nakayama T, Fujita M, Ishihara M, Ishihara M, Ogata S, Yamamoto Y, Shimizu M, Maehara T, Kanatani Y and Tachibana S: Improved survival rate by temperature control at compression sites in rat model of crush syndrome. J Surg Res. 188:250–259. 2014. View Article : Google Scholar : PubMed/NCBI
18	Merrick MA: Secondary injury after musculoskeletal trauma: A review and update. J Athl Train. 37:209–217. 2002.PubMed/NCBI
19	Deal DN, Tipton J, Rosencrance E, Curl WW and Smith TL: Ice reduces edema. A study of microvascular permeability in rats. J Bone Joint Surg Am. 84:1573–1578. 2002. View Article : Google Scholar : PubMed/NCBI
20	Tidball JG and Wehling-Henricks M: Damage and inflammation in muscular dystrophy: Potential implications and relationships with autoimmune myositis. Autoimmune myositis. Curr Opin Rheumatol. 17:707–713. 2005. View Article : Google Scholar : PubMed/NCBI
21	Barnett A: Using recovery modalities between training sessions in elite athletes: Does it help? Sports Med. 36:781–796. 2006. View Article : Google Scholar : PubMed/NCBI
22	Murata I, Ooi K, Shoji S, Motohashi Y, Kan M, Ohtake K, Kimura S, Ueda H, Nakano G, Sonoda K, et al: Acute lethal crush-injured rats can be successfully rescued by a single injection of high-dose dexamethasone through a pathway involving PI3K-Akt-eNOS signaling. J Trauma Acute Care Surg. 75:241–249. 2013. View Article : Google Scholar : PubMed/NCBI
23	Scaffidi P, Misteli T and Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:191–195. 2002. View Article : Google Scholar : PubMed/NCBI
24	Lotze MT and Tracey KJ: High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal. Nat Rev Immunol. 5:331–342. 2005. View Article : Google Scholar : PubMed/NCBI
25	Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al: HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248–251. 1999. View Article : Google Scholar : PubMed/NCBI
26	Huang CH, Tsai MS, Chiang CY, Su YJ, Wang TD, Chang WT, Chen HW and Chen WJ: Activation of mitochondrial STAT-3 and reduced mitochondria damage during hypothermia treatment for post-cardiac arrest myocardial dysfunction. Basic Res Cardiol. 110:592015. View Article : Google Scholar : PubMed/NCBI
27	Tissier R, Chenoune M, Pons S, Zini R, Darbera L, Lidouren F, Ghaleh B, Berdeaux A and Morin D: Mild hypothermia reduces per-ischemic reactive oxygen species production and preserves mitochondrial respiratory complexes. Resuscitation. 84:249–255. 2013. View Article : Google Scholar : PubMed/NCBI
28	Yang X, Liu Y, Yang XM, Hu F, Cui L, Swingle MR, Honkanen RE, Soltani P, Tissier R, Cohen MV and Downey JM: Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity. Basic Res Cardiol. 106:421–430. 2011. View Article : Google Scholar : PubMed/NCBI
29	Yenari MA and Han HS: Neuroprotective mechanisms of hypothermia in brain ischemia. Nat Rev Neurosci. 13:267–278. 2012. View Article : Google Scholar : PubMed/NCBI
30	Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, Sapolsky RM and Steinberg GK: Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci. 25:9794–9806. 2005. View Article : Google Scholar : PubMed/NCBI
31	Alam MR, Baetz D and Ovize M: Cyclophilin D and myocardial ischemia-reperfusion injury: A fresh perspective. J Mol Cell Cardiol. 78:80–89. 2015. View Article : Google Scholar : PubMed/NCBI
32	Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, et al: Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature. 434:658–662. 2005. View Article : Google Scholar : PubMed/NCBI
33	Bochaton T, Crola-Da-Silva C, Pillot B, Villedieu C, Ferrera L, Alam MR, Thibault H, Strina M, Gharib A, Ovize M and Baetz D: Inhibition of myocardial reperfusion injury by ischemic postconditioning requires sirtuin 3-mediated deacetylation of cyclophilin D. J Mol Cell Cardiol. 84:61–69. 2015. View Article : Google Scholar : PubMed/NCBI
34	Liu J, Wang Y, Zhuang Q, Chen M, Wang Y, Hou L and Han F: Protective effects of cyclosporine A and hypothermia on neuronal mitochondria in a rat asphyxial cardiac arrest model. Am J Emerg Med. 34:1080–1085. 2016. View Article : Google Scholar : PubMed/NCBI
35	Patil KD, Halperin HR and Becker LB: Cardiac arrest: Resuscitation and reperfusion. Circ Res. 116:2041–2049. 2015. View Article : Google Scholar : PubMed/NCBI